Kokthansogreta.nu - Nyhetssök / News Search ! » MD Anderson Cancer Center

« Expand/Collapse

MD Anderson Cancer Center - News Releases (75 unread)

Skip to page: 1 2

January 07, 2016
15:41
MD Anderson and Kymab announce research and development strategic partnership in immuno-oncology
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Kymab, a leading human monoclonal antibody biopharmaceutical company, and The University of Texas MD Anderson Oncology Research for Biologics and Immunotherapy Translation (ORBIT) unit today announced a strategic cancer drug discovery and development alliance.
January 06, 2016
17:40
Lymphoma/Myeloma symposium for patients and caregivers set for Feb. 6
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Patients with lymphoma or myeloma and their caregivers will have access to leading experts in this field of cancer during an upcoming symposium to be held Feb. 6 in San Antonio.
17:40
Lymphoma/Myeloma symposium for patients and caregivers set for Feb. 6
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Patients with lymphoma or myeloma and their caregivers will have access to leading experts in this field of cancer during an upcoming symposium to be held Feb. 6 in San Antonio.
December 31, 2015
15:39
Sugar in Western diets increases risk for breast cancer tumors and metastasis
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The high amounts of dietary sugar in the typical Western diet may increase the risk of breast cancer and metastasis to the lungs, according to a study at The University of Texas MD Anderson Cancer Center.
15:39
Sugar in Western diets increases risk for breast cancer tumors and metastasis
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The high amounts of dietary sugar in the typical Western diet may increase the risk of breast cancer and metastasis to the lungs, according to a study at The University of Texas MD Anderson Cancer Center.
December 21, 2015
19:12
Immune suppressor cells identified for advanced prostate cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
December 17, 2015
17:00
Pancreas cancer liquid biopsy flows from blood-borne packets of tumor genes
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Pancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis with a liquid biopsy, researchers at The University of Texas MD Anderson Cancer Center report online at the Annals of Oncology.
December 10, 2015
17:04
Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple-negative breast cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Postponing the start of adjuvant chemotherapy for more than 90 days following surgery may significantly increase risk of death for breast cancer patients, particularly those with triple-negative breast cancer (TNBC), according to a new study from The University of Texas MD Anderson Cancer Center.
15:03
Mastectomy plus reconstruction has highest rate of complication, complication-related costs of guideline-concordant therapies for early breast cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

n a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
December 08, 2015
15:35
Multiple myeloma patient study shows promise for natural killer cells
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A first-in-human Phase I study of multiple myeloma patients combined expanded cord blood-derived natural killer cells with transplantation of a patient's own stem cells and high-dose chemotherapy with little or none of the side effects seen with current treatments.
December 07, 2015
22:47
Loss of enzyme promotes tumor progression in endometrial cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Scientists have shown for the first time why loss of the enzyme CD73 in human cancer promotes tumor progression.
17:49
Study shows ibrutinib superior to traditional chemotherapy in untreated chronic leukemia patients
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL) demonstrated that ibrutinib, a kinase inhibitor, is significantly more effective than traditional chemotherapy with chlorambucil.
December 03, 2015
22:50
Depressed head and neck cancer patients three-and-one-half times less likely to survive, have higher recurrence risk
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Depression is a significant predictor of five-year survival and recurrence in head and neck cancer patients, according to a new study from The University of Texas MD Anderson Cancer Center.
December 02, 2015
22:41
Boehringer Ingelheim and MD Anderson join forces to discover new treatment approaches for pancreatic cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced a collaboration focused on developing innovative medicines for pancreatic ductal adenocarcinoma (PDAC).
December 01, 2015
19:11
Complete surgical excision is the most effective treatment for breast implant-associated anaplastic large-cell lymphoma
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The optimal treatment approach for most women with breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is complete surgical excision of the implant and surrounding capsule, according to an international study led by researchers at The University of Texas MD Anderson Cancer Center.
November 23, 2015
18:05
Two MD Anderson faculty named as prestigious AAAS Fellows
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Distinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough advances in treating breast cancer have earned two scientists at The University of Texas MD Anderson Cancer Center membership in a notable association of scholars.
November 20, 2015
18:52
Tumor-suppressor p53 regulates protein that stifles immune attack on cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A crucial tumor-thwarting gene protects an immune attack against lung cancer by blocking the key to an off switch on T cells, the customized warriors of the immune system, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Institute.
17:07
MD Anderson receives $22.2 million in CPRIT research funding
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center was awarded more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas (CPRIT).
November 17, 2015
15:14
ARCH Venture Partners, Flagship Ventures and MD Anderson collaborate to launch Codiak BioSciences
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Codiak BioSciences, Inc. announced today the closing of the first portion of a planned $80-plus million Series A and B financing.
November 16, 2015
23:21
Research points to why some colorectal cancers recur after treatment
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Cetuximab, marketed as Erbitux®, is one of the key therapies for metastatic colorectal cancer. Yet the cancer still returns in some patients, shortening overall survival.
13:54
New York businessman, philanthropist gives $30 million to cancer research
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Andy Sabin, of East Hampton, N.Y., has committed $30 million -- the philanthropist's largest grant to date -- to support research at The University of Texas MD Anderson Cancer Center.
November 11, 2015
20:06
Study reveals why chemotherapy may be compromised in patients with pancreatic cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A study at The University of Texas MD Anderson Cancer Center may explain why chemotherapy drugs such as gemcitabine are not effective for many pancreatic cancer patients, and perhaps point to new approaches to treatment including enhancing gemcitabine's ability to stop tumor growth.
November 09, 2015
22:44
Dallas A Conversation With a Living Legend® to honor Dr. Condoleezza Rice
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Former Secretary of State Condoleezza Rice is the honoree of A Conversation With a Living Legend®, benefiting The University of Texas MD Anderson Cancer Center, Tuesday Dec. 1 at the Hilton Anatole in Dallas.
15:33
Increased meat consumption, especially when cooked at high temperatures, linked to elevated kidney cancer risk
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Diets high in meat may lead to an increased risk of developing renal cell carcinoma (RCC) through intake of carcinogenic compounds created by certain cooking techniques, such as barbecuing and pan-frying.
November 05, 2015
21:14
CytomX and MD Anderson Cancer Center Enter Into Strategic Collaboration for Probody-Enabled CAR-NK Cell Therapies
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

CytomX Therapeutics (Nasdaq: CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today entered into a collaboration with The University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.
19:21
First precision medicine trial in cancer prevention identifies molecular-based chemoprevention strategy
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A team of scientists, led by researchers at The University of Texas MD Anderson Cancer Center and University of California, San Diego Moores Cancer Center, report that a genetic biomarker called loss of heterozygosity or LOH is able to predict which patients with premalignant mouth lesions are at highest risk of developing oral cancer.
October 29, 2015
14:15
MD Anderson's moon shots mission grows to confront six more cancer types
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

MD Anderson's Moon Shots Program, an unprecedented effort and novel organizational model designed to more rapidly convert scientific discoveries into life-saving advances, has expanded its targets, adding several of the most intractable cancers to its campaign.
October 19, 2015
17:18
'Reversible' tumor suppressor loss: key to new brain cancer therapies?
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

It's no surprise that people enjoy warm places like Hawaii but may suffer in hostile locales such as Antarctica. A tumor suppressor gene called PTEN is similar in that it is affected by the microenvironments of certain bodily organs to which it travels.
16:12
For lung cancer patients, IMRT associated with lesser side effects, better tolerance of chemotherapy, compared to conventional radiation therapy
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

An analysis of an international, cooperative-led trial of patients with locally advanced non-small cell lung cancer (NSCLC) has shown that those who received intensity modulated radiation therapy (IMRT) had less severe lung toxicity and were able to better tolerate their chemotherapy, compared to patients who received 3-dimensional conformal radiation therapy (3-D CRT).
October 15, 2015
19:10
Study reveals why cancer anemia treatment leads to tumor growth
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Scientists have shown why a drug widely used to treat chemotherapy-induced anemia in ovarian and breast cancer patients also may shorten survival times in some patients by inadvertently stimulating tumor growth.
October 14, 2015
21:55
'Until 20' Shares Courageous Story, Challenges All to Lead a Giving Life
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Like the film itself, the world premiere of "Until 20" at the Austin Film Festival will be a celebration of James Ragan's life and his passion for family, friends, sports, a cure for childhood cancers and the mission of MD Anderson Cancer Center.
17:57
MD Anderson to honor Houston Texans founder Bob McNair
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Robert C. "Bob" McNair, founder, chairman and CEO of the Houston Texans, will be honored Nov. 4 at the eighth annual A Conversation With a Living Legend® in Houston benefiting The University of Texas MD Anderson Cancer Center.
October 09, 2015
18:39
MD Anderson Cancer Center Board of Visitors welcomes 14 new members
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center Board of Visitors, an appointed board of volunteers charged with advancing MD Anderson's goal to end cancer, will welcome 14 new members at its annual meeting Oct. 28-29 in Houston.
October 06, 2015
15:07
MD Anderson, Theraclone Sciences form OncoResponse
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

OncoResponse, an immuno-oncology antibody discovery company, has been launched jointly by The University of Texas MD Anderson Cancer Center and Theraclone Sciences.
October 02, 2015
14:37
MD Anderson's Allison wins American Cancer Society medal of honor
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A career-long fascination with discovering the ins and outs of T cells, our immune system's tailor-made destroyers of infections and dysfunctional cells, has earned Jim Allison, Ph.D., the American Cancer Society's 2015 Medal of Honor for Basic Research.
October 01, 2015
19:13
Study shows new 'driver' to assess cancer patient survival and drug sensitivity
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Cancer specialists have long looked at genetic mutations and DNA copy changes to help predict patient survival and drug sensitivity. A study led by The University of Texas MD Anderson Cancer Center has opened up yet another avenue for understanding the biological reasons why some people live longer or respond better to treatment - RNA editing events.
September 26, 2015
20:33
Everolimus provides new hope for neuroendocrine tumours
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced, nonfunctional neuroendocrine tumors (NET) of the lung and gastrointestinal tract.
September 25, 2015
20:31
Breakthrough study demonstrates survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited. Researchers at The University of Texas MD Anderson Cancer Center demonstrated a median overall survival benefit of 25 months with nivolumab, a Food and Drug Administration (FDA)-approved immunotherapy agent, compared with 19.6 months for everolimus, a current standard of care for patients with metastatic kidney cancer.
September 24, 2015
18:44
MD Anderson study identifies leukemia tumor suppressor
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A protein-coding gene called hnRNP K has been identified as a tumor suppressor for acute myeloid leukemia (AML), a finding that could be important for investigating how best to target treatment of a blood cancer striking mostly older individuals.
September 22, 2015
19:05
A Conversation With a Living Legend returns to San Antonio to honor Emmitt Smith
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center heads to San Antonio Oct. 13 for the sixth annual A Conversation With a Living Legend honoring Pro Football Hall of Fame member and "Dancing with the Stars" champion Emmitt Smith.
19:05
A Conversation With a Living Legend returns to San Antonio to honor Emmitt Smith
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center heads to San Antonio Oct. 13 for the sixth annual A Conversation With a Living Legend honoring Pro Football Hall of Fame member and "Dancing with the Stars" champion Emmitt Smith.
September 15, 2015
19:31
MD Anderson, Cayman Chemical, and Fannin Innovation Studio form therapeutics company
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC.
September 08, 2015
15:19
MD Anderson immunologist Jim Allison wins Lasker-DeBakey Award
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

For inventing a completely new way to strike cancer by unlocking a shackled immune system attack, Jim Allison, Ph.D., chair of Immunology at MD Anderson Cancer Center, will receive the nation's highest honor for clinical medical research
September 03, 2015
21:00
MD Anderson brings Making Cancer History® seminar to Atlanta
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center heads to Atlanta for a Making Cancer History® seminar, 8:30-10 a.m. Friday, Sept. 25 at the Intercontinental Buckhead Atlanta Hotel, 3315 Peachtree Rd. NE.
20:58
MD Anderson and Cellectis announce pre-clinical and clinical alliance in cancer immunotherapy
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Cellectis, the gene editing company employing proprietary technologies to develop best-in-class CAR T-cell products in adoptive immunotherapy for cancer, and The University of Texas MD Anderson Cancer Center have entered into a research and development alliance aimed at bringing novel cellular immunotherapies to patients suffering from different types of liquid tumors.
September 02, 2015
16:37
MD Anderson to honor Houstonians for their efforts to end cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center will host a celebratory reception honoring hundreds of Houston-area donors on Wednesday, Sept. 9 from 6 to 8 p.m. at the River Oaks Country Club, 1600 River Oaks Blvd.
September 01, 2015
17:30
Michelle Barton receives Rogers Award for Excellence in Education
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Michelle Barton, Ph.D., professor, Epigenetics and Molecular Carcinogenesis at MD Anderson Cancer Center, is the 2015 recipient of the Julie and Ben Rogers Award for Excellence in Education.
August 26, 2015
22:08
Internationally recognized health care leader to direct MD Anderson Moon Shots Program prevention efforts
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center has appointed former U.S. Public Health Service four-star Admiral Joxel Garcia, M.D. as the inaugural executive director of the cancer prevention and control platform, part of MD Anderson's Moon Shots Program. He joins MD Anderson on Aug. 31.
21:15
MD Anderson to host evening fun run supporting skin cancer research
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Runners and walkers will hit the streets for the eighth annual AIM for the CURE Melanoma Walk and Fun Run to raise funds and awareness for the disease. The event on Sept. 26 at 6 p.m. is co-hosted by MD Anderson Cancer Center and The AIM at Melanoma Foundation.
8:32
Immatics and MD Anderson announce launch of Immatics US, Inc., to develop multiple T-cell and TCR-based adoptive cellular therapies
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Immatics Biotechnologies GmbH (Immatics) and MD Anderson Cancer Center announced today the launch of Immatics US, Inc., a new company aiming at becoming a global leader in adoptive cellular therapies (ACT) for the treatment of a range of tumor types.
August 23, 2015
13:27
Generic heart medication shown to prolong ovarian cancer patients' survival
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

In a first-of-its-kind study, researchers demonstrate a benefit in overall survival among epithelial ovarian cancer (EOC) patients receiving generic heart medications known as beta-blockers.
August 20, 2015
15:20
MD Anderson to build new outpatient center in West Houston
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

With the approval of The University of Texas System Board of Regents today, MD Anderson Cancer Center is one step closer to developing and building its own outpatient diagnostic and treatment center to better serve the growing communities of West Houston and beyond.
15:16
UTMB, MD Anderson to collaborate on League City campus
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas Medical Branch at Galveston and MD Anderson Cancer Center have signed a first-ever clinical collaboration agreement, which today was approved by The University of Texas System Board of Regents.
August 17, 2015
17:42
MD Anderson study reveals new insight into tumor progression
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17:42
MD Anderson study reveals new insight into tumor progression
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
August 13, 2015
14:53
Merck and MD Anderson announce immuno-oncology research collaboration in solid tumors
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Merck and MD Anderson Cancer Center announced a strategic clinical research collaboration to evaluate Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel anti-tumor medicines.
August 12, 2015
21:18
Helping preschoolers deploy 'superpowers' against sunburn
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Five globe-trotting, sun-blocking superheroes teach preschoolers about lifelong sun safety in a new curriculum available this summer based on research at The University of Texas MD Anderson Cancer Center.
August 10, 2015
22:22
MD Anderson names Valerae O. Lewis, M.D., chair of Orthopaedic Oncology
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Internationally respected surgeon, Valerae O. Lewis, M.D., has been named chair of Orthopaedic Oncology at MD Anderson Cancer Center.
22:22
MD Anderson names Valerae O. Lewis, M.D., chair of Orthopaedic Oncology
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Internationally respected surgeon, Valerae O. Lewis, M.D., has been named chair of Orthopaedic Oncology at MD Anderson Cancer Center.
22:20
Poor survival among colorectal cancer patients tied to biomarker CSN6
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at MD Anderson Cancer Center.
22:20
Poor survival among colorectal cancer patients tied to biomarker CSN6
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at MD Anderson Cancer Center.
August 06, 2015
17:31
Shorter course of radiation therapy associated with less toxicity
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Women who receive a shorter course of whole breast radiation therapy for early stage disease experience less toxicity and improved quality of life compared to those who undergo a longer course of treatment, researchers report from The University of Texas MD Anderson Cancer Center.
August 03, 2015
17:31
Potential new therapy approaches to reverse kidney damage identified
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Adults who are worried or terrified sometimes curl up into a fetal position. Likewise, adult cells that are injured, including genetic injury leading to cancer, initiate a process that was present during embryonic development.
17:10
MD Anderson study reveals new insight into DNA Repair
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

DNA double-strand breaks (DSBs) are the worst possible form of genetic malfunction that can cause cancer and resistance to therapy. New information published this week reveals more about why this occurs and how these breaks can be repaired.
July 23, 2015
0:22
MD Anderson presents Making Cancer History seminar in Santa Fe
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center will host a Making Cancer History® seminar in Santa Fe, 11:30 a.m. to 1 p.m. on Thursday, Aug. 6 at the Inn and Spa at Loretto, 211 Old Santa Fe Trail.
July 22, 2015
18:06
MD Anderson named as one of two Genome Characterization Centers
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center has been named a site for one of two new Genome Characterization Centers (GCC) funded through the National Cancer Institute (NCI).
July 21, 2015
6:39
MD Anderson named top-ranked hospital for cancer care
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report's "Best Hospitals" survey.
July 20, 2015
22:35
MD Anderson study finds one-third of colorectal cancers diagnosed before age 35 are hereditary
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients. However, researchers at The University of Texas MD Anderson Cancer Center have discovered a particularly high prevalence of hereditary cancers among those diagnosed with the disease before the age of 35. They suggest that these patients should undergo genetic counseling to determine if their families may be at an elevated risk.
July 16, 2015
14:22
Can protein 14-3-3 sigma prevent or kill breast cancer tumors?
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

MD Anderson study shows potential of simple molecule in cancer metabolism

Every parent knows the maxim "feed a cold, starve a fever." In cancer, however, exactly how to feed or starve a tumor has not been easy to determine.
June 30, 2015
14:31
Similarities between embryos and breast tumors identified
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

MD Anderson researchers find that metastatic tumors behave like embryonic stem cells

It may seem incredulous, but breast tumors may have something in common with embryos ... at least in mice, say researchers at The University of Texas MD Anderson Cancer Center.
14:20
MD Anderson names new vice provost, clinical and interdisciplinary research
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center is pleased to announce the appointment of George Wilding, M.D., as vice provost for clinical and interdisciplinary research. Dr. Wilding's appointment at MD Anderson will begin on September 1st.
June 24, 2015
19:48
Tiny particles in blood useful for early diagnosis of pancreatic cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

A protein encoded by the gene glypican-1 (GPC1) present on cancer exosomes may be used as part of a potential non-invasive diagnostic and screening tool to detect early pancreatic cancer, potentially at a stage amenable to surgical treatment, according to a study at The University of Texas MD Anderson Cancer Center.
17:52
Keys to prevention: MD Anderson leaders share latest news in fight to end cancer
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The University of Texas MD Anderson Cancer Center heads to Aspen this summer for its 17th annual Making Cancer History® seminar. The free event is slated for 1-3 p.m. on July 16 at Aspen Meadows Resort's Paepcke Auditorium, 1000 N. Third St.
June 23, 2015
14:44
Current blood cancer drug prices not justified, MD Anderson study finds
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

The costs associated with cancer drug prices have risen dramatically over the past fifteen years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States. Their findings are published in the current issue of the journal Cancer.
June 18, 2015
14:43
Genomic discovery of skin cancer subtypes provides potential 'signpost' for drug targets
» ‎ MD Anderson Cancer Center - News Releases

Tags: [edit]

Cutaneous melanoma, the most deadly form of skin cancer, is now believed to be divided into four distinct genomic subtypes, say researchers at The University of Texas MD Anderson Cancer Center, a finding that could prove valuable in the ever-increasing pursuit of personalized medicine.

Skip to page: 1 2

← Mazocialmedia's Blog med socker i blodet och en vilja av j... →

Kokthansogreta.nu - Nyhetssök / News Search ! » MD Anderson Cancer Center - News Releases

Feeds

MD Anderson Cancer Center - News Releases (75 unread)

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]

Tags: [edit]